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Recent results show that chemokine receptors and
adhesion molecules can be differentially expressed on
the different subsets of T helper cells, suggesting that
regulated networks of gene expression may control
tissue-specific migration of T helper cells. 
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Early events in an immune response stimulate the produc-
tion of cytokines that direct the subsequent development of
the different subsets of T helper (Th) cells which them-
selves have discrete patterns of cytokine production [1].
The development of these distinct Th subsets is strongly
dictated by the type of microorganism invading a host, as
well as by the genetic background of the host, probably as a
result of the cytokines induced. It is likely that the dose of
antigen and the route of antigen immunization may also be
factors that determine the development of Th subsets [2–5]. 
Th1 cells, through their production of interferon-γ (IFN-γ)
and tumour necrosis factor β, are responsible for directing
cell-mediated immune responses leading to the eradica-
tion of intracellular pathogens [6,7] and may also cause
diseases of the immune system, such as organ-specific
autoimmune disease, if deregulated [8–10]. Th2 cells have
been implicated in allergic inflammation, as cytokines pro-
duced by these cells, such as interleukin-4 (IL-4) and
IL-5, can activate mast cells and eosinophils and, in addi-
tion, can result in elevated levels of immunoglobulin E
[11]. The production of B-cell growth and differentiation
factors by Th2 cells may in part explain why certain
immune responses are predominantly antibody-mediated.
However, it should be noted that delayed-type hypersen-
sitivity responses, which are mediated by Th1 cells, are
often accompanied by the production of complement-
fixing antibodies such as immunoglobulin G2a [2,3,7].
The ability of cytokines to stimulate different effector
mechanisms and thus different immune responses is also
revealed by the fact that cytokines produced by each
subset can regulate the function as well as the develop-
ment of each subset [2,3,7].
An additional layer of control of the immune response
depends on the regulated trafficking of lymphocyte subsets
to the specialized microenvironments that control their dif-
ferentiation and regulate their survival. Recruitment or
homing of lymphocytes to these microenvironments is 
regulated by sequential engagement of adhesion and sig-
naling receptors. This process can be separated into the fol-
lowing successive steps: primary, transient adhesion or
tethering of the lymphocyte to the endothelium of the
blood vessel; rolling of the cell along the endothelium; cel-
lular activation through G-protein-coupled receptors; acti-
vation-dependent arrest; movement of the lymphocyte
through the endothelium out of the blood vessel; and
finally, further migration and localization within microenvi-
ronments in the tissue [12,13]. 
The exquisite specificity of lymphocyte homing is derived
from the use of unique combinations of independently
regulated receptor–ligand interactions at each of the
sequential steps. Whereas the homing behavior of naive T
cells — those that have not encountered antigen — is rela-
tively homogeneous, the homing behavior of memory and
effector T cells — those that have encountered antigen —
is extremely heterogeneous with distinct subsets display-
ing restricted, tissue-selective patterns of recirculation
[12]. Differential trafficking of naive and memory/effector
cells implies that, during the naive to memory/effector
transition, which is under the influence of the local envi-
ronment, cells upregulate a unique set of homing recep-
tors and chemokine receptors allowing them to selectively
localize to appropriate effector sites outside the blood-
stream and lymphoid organs. 
Acquisition of a novel homing phenotype during
memory/effector T-cell differentiation is temporally con-
comitant with the effector cytokine production associated
with differentiation of Th effector cells such as Th1 and
Th2 cells. Given their distinct effector functions, it seems
likely that these Th effector cell subsets will be differen-
tially recruited to sites of inflammation. The mechanisms
responsible for the differential recruitment are now begin-
ning to be elucidated. In this context, it has recently been
shown that a percentage of Th1 cells, but not Th2 cells, is
able to bind the adhesion molecule P-selectin and that
these cells are selectively recruited to sites where Th1-
mediated immune responses occur. Only Th1 cells can
efficiently enter sites of inflammation where the immune
response involves predominantly Th1 cells, for example
sensitized skin or arthritic joints. This can be partially
blocked by antibodies directed against P-selectin and
further blocked by anti-E-selectin antibodies, even though
soluble E-selectin binds poorly to Th1 cells [14]. Th2 cells
that express the ligand for E-selectin do not home to the
skin in these Th1-mediated immune responses [14].
However, it is possible that, under different immunizing
regimens, Th2 cells may also be recruited.
Chemokines are pro-inflammatory cytokines that are
involved in leukocyte recruitment and activation and have
been divided into four classes — C–C, C–X–C, C–X3–C
and C — on the basis of the number and spacing of the
conserved cysteine residues in their sequences [15]. The
biological effects of chemokines on target cells are medi-
ated by their interaction with seven-transmembrane G-
protein-coupled receptors [15]. Given the heterogeneous
localization of memory/effector cells, the distinct effector
function of Th1 and Th2 subsets, and the model that lym-
phocyte recruitment is directed by a unique combination
of adhesion molecules and chemokine receptors, it is
perhaps not surprising that a rather striking pattern of
expression of chemokine receptors on Th1 and Th2
subsets is emerging (Table 1). Whereas some of these
receptors appear to be relatively stably expressed follow-
ing Th1 and Th2 differentiation, the expression of other
receptors appears to be more variable, potentially reflect-
ing the activation state of the cells [15–21].
Effects of activation on the expression of chemokine
receptors on T cells
Naive T lymphocytes do not respond to chemokines that
are frequently produced as a result of inflammation.
Chemotactic migration and the expression of CCR1, CCR2
and CCR5 have been shown to depend on the activation
state of T cells and in particular on the presence of IL-2
[18,19,22,23]. In contrast, CXCR4 is expressed on both
resting and activated T lymphocytes [15]. Of the receptors
of the CXC class, naive T cells isolated from human
peripheral blood lymphocytes have been shown to express
only CXCR4, whereas other reports offer conflicting infor-
mation on CXCR4 expression on polarized Th1 and Th2
cell lines, that is, cell lines that have been induced to dif-
ferentiate down the Th1 or Th2 pathway [17,20].
Loetscher et al. [18] have shown that there is a significant
variability in CCR5 expression and responsiveness to MIP-
1β in T-cell lines generated from human donors by cocul-
ture with IL-2. They went on to show that, like CCR1 and
CCR2 [18], CCR5 was rapidly lost in the absence of IL-2,
and activation by antibodies against the T-cell accessory
receptors CD3 and CD28 also resulted in CCR5 downreg-
ulation and loss of migration [19]. In this same study, they
also showed that CXCR3 was present on Th1 and Th2
cells and T-cell lines cultured with IL-2. Whereas the
majority of memory/effector T cells has been shown to
express CXCR3, only a small proportion expresses CCR3
and CCR5 [17].
Th1-specific expression of chemokine receptors
CXCR3 has now been shown to be differentially
expressed on lymphocytes and to bind the IFN-γ-
inducible chemokines IP-10 and MIG [24]; moreover, it is
expressed at much higher levels on Th1 cells and Th0
cells (which express both Th1-specific and Th2-specific
cytokines) than on Th2 cells [17,20,25]. The migration of
Th1 and Th0 cells to sites of inflammatory lesions in
which high levels of IFN-γ are expressed may be favored
by the responsiveness of the cells to IP-10 and MIG,
together with their expression of functional ligands for P-
selectin and E-selectin [14]. In fact, it has recently been
reported that virtually all T cells that infiltrate joints
affected by rheumatoid arthritis express CXCR3 [19].
CCR5, the receptor for RANTES, MIP-1α and MIP-1β,
has been shown to be expressed at variable levels on T
cells, unlike CXCR3: in some cases, CCR5 was detected
on Th1 and Th2 cell lines [17] and, in other cases, it was
found at higher levels on Th1 cell lines and clones than on
Th2 cells [17,20]. This variability may be explained by the
observation that CCR5 expression is influenced by the T-
cell activation state and, like other receptors [18], is upreg-
ulated by IL-2 [22]. Expression of CXCR3 may not be
affected significantly by the activation state, which may
explain why it is detectable on a higher percentage of
memory T cells [17]. Th1 lymphocytes expressing CCR5
as well as CXCR3 have been shown to predominate in the
rheumatoid synovium [19]. 
Th2-specific expression of chemokine receptors
A number of studies have confirmed the initial observa-
tion [16] that CCR3 expression is restricted to Th2 cells
[17,19,20]. Like CCR1, CCR2 and CCR5 [19], CCR3 is
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Table 1
Differential expression of chemokine receptors.
Receptor T cells Other Chemokine ligand
CCR1 + Eosinophil MIP-1α,1β, RANTES 
(MCP-3,4 low)
CCR2 + Monocyte/basophil MCP-1,2,3,4
CCR3 Th2 Eosinophil/basophil MCP-3,4, eotaxin 1,2, 
RANTES
CCR4 Th2 Basophil TARC, MDC
CCR5 Th1, Th2± Monocyte, DC? MIP-1α,1β, 
RANTES
CCR6 ? DC MIP-3α
CCR7 + DC MIP-3β, 6Ckine
CCR8 Th2 Monocyte, thymocyte I-309, TARC
CXCR1 ? ? IL-8, GCP-2
CXCR2 ? Neutrophil IL-8, GCP-2, GROα,β,γ,
ENA-78, NAP-2, LIX
CXCR3 Th1, Th2± NK? IP-10, MIG, 6Ckine
CXCR4 Naive, – SDF-1
activated
CXCR5 – B cell BCA-1/BLC
± denotes that receptor expression was detectable in some but not all
studies. NK, natural killer cell. DC, dendritic cell. For definitions of
chemokines, see [15].
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downregulated on T-cell activation [16]. Levels of CCR3
have been shown to be moderate and variable in a number
of studies [19,20], suggesting that CCR3-expressing lym-
phocytes might constitute a subpopulation of Th2 cells.
However, Sallusto et al. [17], have demonstrated by flow
cytometry that antibodies against CCR3 stain all of the
cells within a population of Th2 cells, albeit with a hetero-
geneous pattern of expression, suggesting that different
levels of CCR3 may be expressed on populations of Th2
cells but that all Th2 cells express CCR3. This idea is sup-
ported by the observation that there is enhanced CCR3
expression on Th2 cell lines that had been polarized
through two rounds of stimulation in the presence of IL-4
and anti-IL-12 antibodies, in contrast to those obtained
after one round of polarization [17]. The variability of
CCR3 expression in Th2 populations may therefore repre-
sent various stages of polarization, as has been previously
shown for differences in cytokine production by differen-
tiating populations of Th2 cells [26]. In agreement with its
expression on Th2 cells, the CCR3 receptor is a character-
istic feature of T lymphocytes recruited into eosinophil-
rich sites of allergic inflammation [27]. Furthermore, Th2
lymphocytes expressing CCR3 have been frequently
found in allergic infiltrates [27].
Emerging studies now indicate that CCR3 is not the only
chemokine receptor that is preferentially expressed on
Th2 cells. Other such receptors expressed on Th2 but not
on Th1 cells include CCR4 [16,19] as well as CCR8 [28].
Interestingly, both these receptors bind a common ligand
termed TARC for thymus- and activation-regulated
chemokine, although CCR4 and CCR8 each also bind
MDC and I-309, respectively [16,28]. Furthermore, CCR3
expression is also observed on eosinophils and basophils,
whereas CCR4 is expressed only on basophils (reviewed
in [21]), and CCR8 is expressed only on monocytes [29].
This overlap in expression of chemokine receptors on Th2
cells and other effector cells involved in allergic responses
is likely to represent a global mechanism for the recruit-
ment of effector cells during allergic responses. 
Ligands for CCR3, CCR4 and CCR8 may selectively
attract not only eosinophils, basophils and monocytes, but
also Th2 cells; upon activation with antigen, Th2 cells will
produce IL-4 and IL-5 which induce the activation and
survival of the key effector cells during allergic responses
[2,3,7,11]. It will be of interest to determine whether these
receptors are regulated by different stimuli or at discrete
times in an allergic response. In this context, Sallusto et al.
[17] have recently shown that polarization of T cells under
conditions that favor the Th2 phenotype (treatment with
IL-4 and anti-IL-12 antibodies) but in the presence of
IFN-α not only inhibits differentiation of Th2 cells and
IL-4 production, but also blocks the expression of both
CCR3 and CCR4. In contrast, transforming growth factor
β (TGF-β) inhibited Th2 development, IL-4 production
and CCR3 expression, but enhanced the expression of
CCR4 [17]. In addition, TGF-β enhanced the expression
of another chemokine receptor CCR7, which is also found
on naive T cells [17].
Implicit in the differential trafficking and function of
naive, memory and effector T-cell subsets is the concept
that expression of adhesion molecules, cytokines,
chemokines and chemokine receptors can be repeatedly
regulated during the life span of the lymphocyte, not only
during antigen-induced differentiation but also under the
influence of the local microenvironment. These findings
raise the possibility that the expression of certain
chemokine receptors on Th cells may be developmentally
regulated in accordance with the expression of key Th1 or
Th2 cytokines, receptors for these cytokines and/or tran-
scription factors. In contrast, the expression of other
chemokine receptors may be less rigid and may be regu-
lated independently of factors involved in the commit-
ment of the Th1 and Th2 phenotype [17]. 
The differential expression of particular chemokine recep-
tors on naive T cells as well as on Th1 and Th2 subsets
suggests that regulated networks of chemokine receptor
gene expression control the tissue-specific migration of
Th effector cells [17]. It is possible that the expression of
chemokines and their receptors by cells recruited to the
site of an immune response may eventually provide a
‘road map’ for the identification of specific cell types par-
ticipating in a given class of immune response. It is likely
that the relative levels of cytokines may differ, however,
often resulting in the development of Th1, Th2 and Th0
cells within an immune response. Thus, alternative levels
of regulation may first differentially recruit subsets of cells
and then may maintain a polarized reaction within a local
site, allowing the possibility of an oppositely polarized
reaction at a distinct site. Clearly, the kinetics of expres-
sion of cytokines as well as the expression of chemokines
and their receptors will determine the activation, differen-
tiation and recruitment of discrete Th effector subsets
during an immune response.
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